Evidence map›Paper›PMID 40978995›Full record

ArticleCureus2025

Primary Malignant Mesothelioma of the Tunica Vaginalis Presenting as a Benign Scrotal Mass: A Case Report.

Zihni Can Dagdeviren, Onur Amac, Yelda Dere, Engin Derekoylu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zihni Can DagdevirenUrology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, TUR.
Onur AmacPathology and Laboratory Medicine, Mugla Sitki Kocman University, Mugla, TUR.
Yelda DerePathology and Laboratory Medicine, Mugla Sitki Kocman University, Mugla, TUR.
Engin DerekoyluUrology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary malignant mesothelioma of the tunica vaginalis is an exceptionally uncommon neoplasm, comprising a very small fraction of all mesothelioma cases. Due to its nonspecific clinical presentation, it is frequently misdiagnosed as benign scrotal conditions, such as a hydrocele. In our case, a 77-year-old male presented with a gradually enlarging swelling in the left hemiscrotum. Scrotal Doppler ultrasonography (USG) and magnetic resonance imaging (MRI) revealed a hydrocele with polypoid masses and nodular soft tissue components of the tunica vaginalis. Tumor markers were normal. Surgical exploration revealed multiple solid masses on the testis and spermatic cord. Histopathologic examination confirmed malignant mesothelioma of epithelioid type, supported by immunohistochemical reactivity for calretinin, cytokeratin 7 (CK7), cytokeratin 5/6 (CK5/6), pan-cytokeratin (PanCK), Wilms tumor 1 (WT1), and loss of BRCA1-associated protein-1 (BAP1). Following the diagnosis of primary tunica vaginalis mesothelioma, the patient underwent radical inguinal orchiectomy and hemiscrotectomy. Adjuvant chemotherapy with pemetrexed and cisplatin was administered. No recurrence was detected after seven cycles, and the patient remains disease-free. This case highlights the diagnostic challenges of tunica vaginalis mesothelioma because of its infrequency and clinical similarity with benign processes. Diagnosis needs to be based on multimodal imaging, histopathology, and immunohistochemistry. Early and total surgical intervention followed by adjuvant therapy may hold the key to successful treatment.

Indexed as

hemi scrotumhydrocelemalignant mesotheliomatunica vaginalis tumorurology and oncology

Identifiers

PMID40978995
PMCPMC12448781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.